PON1 and metabolic dysfunction-associated steatotic liver disease: Parallel to previous studies (Attia et al. 2022; Bae et al. 2024), NAFLD development in mice was accompanied by enhanced oxidative stress, as manifested by elevated MDA levels and reduced PON1 activity.